BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma

Conditions:   Multiple Myeloma in Relapse;   Refractory Multiple Myeloma;   Plasmacytoid; Lymphoma Intervention:   Biological: BCMA-CD19 cCAR T cells Sponsors:   iCell Gene Therapeutics;   iCAR Bio, China Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials